The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Type 2 inflammation in asthma — present in most, absent in many
Open accessAbstract
Asthma is one of the most common chronic immunological diseases in humans, affecting people from childhood to old age. Progress in treating asthma has been relatively slow and treatment guidelines have mostly recommended empirical approaches on the basis of clinical measures of disease severity rather than on the basis of the underlying mechanisms of pathogenesis. An important molecular mechanism of asthma is type 2 inflammation, which occurs in many but not all patients. In this Opinion article, I explore the role of type 2 inflammation in asthma, including lessons learnt from clinical trials of inhibitors of type 2 inflammation. I consider how dichotomizing asthma according to levels of type 2 inflammation — into 'T helper 2 (TH2)-high' and 'TH2-low' subtypes (endotypes) — has shaped our thinking about the pathobiology of asthma and has generated new interest in understanding the mechanisms of disease that are independent of type 2 inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arzneimittelforschung: Erstanwendung am Menschen in der Phase I
Miletzki, B., & Gleiter, C. H. (2005) · Bundesgesundheitsblatt Gesundheitsforsch.Gesundheitsschutz · doi:10.1007/s00103-005-1024-7 · Cited by 9,355
Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
Ortega, H. G., Liu, M. C., Pavord, I. D., Brusselle, G. G., FitzGerald, J. M., Chetta, A., Humbert, M., Katz, L. E., Keene, O. N., Yancey, S. W., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1403290 · Cited by 2,322
Pavord, I. D., Korn, S., Howarth, P., Bleecker, E. R., Buhl, R., Keene, O. N., Ortega, H., & Chanez, P. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60988-x · Cited by 2,221
Identification of Asthma Phenotypes Using Cluster Analysis in the Severe Asthma Research Program
Moore, W. C., Meyers, D. A., Wenzel, S. E., Teague, W. G., Li, H., Li, X., D'Agostino, R., Castro, M., Curran-Everett, D., Fitzpatrick, A. M., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200906-0896oc · Cited by 2,129
Cluster analysis and clinical asthma phenotypes
Haldar, P., Pavord, I. D., Shaw, D. E., Berry, M. A., Thomas, M., Brightling, C. E., Wardlaw, A. J., & Green, R. H. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200711-1754oc · Cited by 1,987
Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
Haldar, P., Brightling, C. E., Hargadon, B., Gupta, S., Monteiro, W., Sousa, A., Marshall, R. P., Bradding, P., Green, R. H., Wardlaw, A. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808991 · Cited by 1,871
A large-scale, consortium-based genomewide association study of asthma
Moffatt, M. F., Gut, I. G., Demenais, F., Strachan, D. P., Bouzigon, E., Heath, S., von Mutius, E., Farrall, M., Lathrop, M., & Cookson, W. O. C. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0906312 · Cited by 1,818
T-helper Type 2–driven Inflammation Defines Major Subphenotypes of Asthma
Woodruff, P. G., Modrek, B., Choy, D. F., Jia, G., Abbas, A. R., Ellwanger, A., Arron, J. R., Koth, L. L., & Fahy, J. V. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200903-0392oc · Cited by 1,803
Self-citationOral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma
Bel, E. H., Wenzel, S. E., Thompson, P. J., Prazma, C. M., Keene, O. N., Yancey, S. W., Ortega, H. G., & Pavord, I. D. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1403291 · Cited by 1,661
Lebrikizumab Treatment in Adults with Asthma
Corren, J., Lemanske, R. F., Hanania, N. A., Korenblat, P. E., Parsey, M. V., Arron, J. R., Harris, J. M., Scheerens, H., Wu, L. C., Su, Z., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1106469 · Cited by 1,514
Mepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia
Nair, P., Pizzichini, M. M. M., Kjarsgaard, M., Inman, M. D., Efthimiadis, A., Pizzichini, E., Hargreave, F. E., & O'Byrne, P. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0805435 · Cited by 1,356
Dupilumab in Persistent Asthma with Elevated Eosinophil Levels
Wenzel, S., Ford, L., Pearlman, D., Spector, S., Sher, L., Skobieranda, F., Wang, L., Kirkesseli, S., Rocklin, R., Bock, B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1304048 · Cited by 1,320
Busse, W., Corren, J., Lanier, B. Q., McAlary, M., Fowler-Taylor, A., Cioppa, G. D., van As, A., & Gupta, N. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.117880 · Cited by 1,307
WENZEL, S. E., SCHWARTZ, L. B., LANGMACK, E. L., HALLIDAY, J. L., TRUDEAU, J. B., GIBBS, R. L., & CHU, H. W. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.3.9812110 · Cited by 1,235
Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease
Anderson, G. P. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61452-x · Cited by 999
Type 1/Type 2 Immunity in Infectious Diseases
Spellberg, B., & Edwards, J. E. (2001) · Clinical Infectious Diseases · doi:10.1086/317537 · Cited by 911
Ying, S., O’Connor, B., Ratoff, J., Meng, Q., Mallett, K., Cousins, D., Robinson, D., Zhang, G., Zhao, J., Lee, T. H., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.8183 · Cited by 873
Green, R. H. (2002) · Thorax · doi:10.1136/thorax.57.10.875 · Cited by 848
Woodruff, P. G., Boushey, H. A., Dolganov, G. M., Barker, C. S., Yang, Y. H., Donnelly, S., Ellwanger, A., Sidhu, S. S., Dao-Pick, T. P., Pantoja, C., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707413104 · Cited by 828
Self-citationSolèr, M., Matz, J., Townley, R., Buhl, R., O'Brien, J., Fox, H., Thirlwell, J., Gupta, N., & Della Cioppa, G. (2001) · European Respiratory Journal · doi:10.1183/09031936.01.00092101 · Cited by 827
Effects of an Anti-TSLP Antibody on Allergen-Induced Asthmatic Responses
Gauvreau, G. M., O'Byrne, P. M., Boulet, L.-P., Wang, Y., Cockcroft, D., Bigler, J., FitzGerald, J. M., Boedigheimer, M., Davis, B. E., Dias, C., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402895 · Cited by 789
A Study to Evaluate Safety and Efficacy of Mepolizumab in Patients with Moderate Persistent Asthma
Flood-Page, P., Swenson, C., Faiferman, I., Matthews, J., Williams, M., Brannick, L., Robinson, D., Wenzel, S., Busse, W., Hansel, T. T., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200701-085oc · Cited by 750
Role of viral respiratory infections in asthma and asthma exacerbations
Busse, W. W., Lemanske, R. F., & Gern, J. E. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61380-3 · Cited by 750
Reslizumab for Poorly Controlled, Eosinophilic Asthma: A Randomized, Placebo-controlled Study
Castro, M., Mathur, S., Hargreave, F., Boulet, L.-P., Xie, F., Young, J., Wilkins, H. J., Henkel, T., & Nair, P. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201103-0396oc · Cited by 716
Fahy, J. V., Fleming, H. E., Wong, H. H., Liu, J. T., Su, J. Q., Reimann, J., Fick, R. B., & Boushey, H. A. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.155.6.9196082 · Cited by 713
Self-citationTreatment of Allergic Asthma with Monoclonal Anti-IgE Antibody
Milgrom, H., Fick, R. B., Su, J. Q., Reimann, J. D., Bush, R. K., Watrous, M. L., & Metzger, W. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912233412603 · Cited by 704
Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease
Barnes, P. J. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.12.1564 · Cited by 694
Myofibroblasts and Subepithelial Fibrosis in Bronchial Asthma
Brewster, C. E. P., Howarth, P. H., Djukanovic, R., Wilson, J., Holgate, S. T., & Roche, W. R. (1990) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb/3.5.507 · Cited by 663
Djukanović, R., Wilson, S. J., Kraft, M., Jarjour, N. N., Steel, M., Chung, K. F., Bao, W., Fowler-Taylor, A., Matthews, J., Busse, W. W., et al. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200312-1651oc · Cited by 646
Self-citationThe Transcription Factor GATA3 Is Essential for the Function of Human Type 2 Innate Lymphoid Cells
Mjösberg, J., Bernink, J., Golebski, K., Karrich, J. J., Peters, C. P., Blom, B., te Velde, A. A., Fokkens, W. J., van Drunen, C. M., & Spits, H. (2012) · Immunity · doi:10.1016/j.immuni.2012.08.015 · Cited by 636
Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients
Jia, G., Erickson, R. W., Choy, D. F., Mosesova, S., Wu, L. C., Solberg, O. D., Shikotra, A., Carter, R., Audusseau, S., Hamid, Q., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.06.025 · Cited by 615
Self-citationMcArdle, M. A., Finucane, O. M., Connaughton, R. M., McMorrow, A. M., & Roche, H. M. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00052 · Cited by 532
Berry, M., Morgan, A., Shaw, D. E., Parker, D., Green, R., Brightling, C., Bradding, P., Wardlaw, A. J., & Pavord, I. D. (2007) · Thorax · doi:10.1136/thx.2006.073429 · Cited by 483
A Large Subgroup of Mild-to-Moderate Asthma Is Persistently Noneosinophilic
McGrath, K. W., Icitovic, N., Boushey, H. A., Lazarus, S. C., Sutherland, E. R., Chinchilli, V. M., & Fahy, J. V. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201109-1640oc · Cited by 478
Self-citationAsthma and Allergic Inflammation
Locksley, R. M. (2010) · Cell · doi:10.1016/j.cell.2010.03.004 · Cited by 408
Inhibitory effects of an anti-IgE antibody E25 on allergen-induced early asthmatic response.
Boulet, L. P., Chapman, K. R., Côté, J., Kalra, S., Bhagat, R., Swystun, V. A., Laviolette, M., Cleland, L. D., Deschesnes, F., Su, J. Q., et al. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.155.6.9196083 · Cited by 399
Acute exacerbations of asthma: epidemiology, biology and the exacerbation‐prone phenotype
Dougherty, R. H., & Fahy, J. V. (2009) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2008.03157.x · Cited by 396
Self-citationEosinophilic and Neutrophilic Inflammation in Asthma: Insights from Clinical Studies
Fahy, J. V. (2009) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200808-087rm · Cited by 389
Self-citationSidhu, S. S., Yuan, S., Innes, A. L., Kerr, S., Woodruff, P. G., Hou, L., Muller, S. J., & Fahy, J. V. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009426107 · Cited by 384
Self-citationBilgiç Temel, A., Bassorgun, C. I., Akman-Karakaş, A., Alpsoy, E., & Uzun, S. (2017) · Case Reports in Dermatology · doi:10.1159/000452828 · Cited by 363
Voehringer, D., Reese, T. A., Huang, X., Shinkai, K., & Locksley, R. M. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052448 · Cited by 348
Measures of gene expression in sputum cells can identify TH2-high and TH2-low subtypes of asthma
Peters, M. C., Mekonnen, Z. K., Yuan, S., Bhakta, N. R., Woodruff, P. G., & Fahy, J. V. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.07.036 · Cited by 342
Self-citationBeale, J., Jayaraman, A., Jackson, D. J., Macintyre, J. D. R., Edwards, M. R., Walton, R. P., Zhu, J., Ching, Y. M., Shamji, B., Edwards, M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009124 · Cited by 332
Gill, M. A., Bajwa, G., George, T. A., Dong, C. C., Dougherty, I. I., Jiang, N., Gan, V. N., & Gruchalla, R. S. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901194 · Cited by 310
Nagarkar, D. R., Poposki, J. A., Tan, B. K., Comeau, M. R., Peters, A. T., Hulse, K. E., Suh, L. A., Norton, J., Harris, K. E., Grammer, L. C., et al. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.04.005 · Cited by 266
Accumulation of intraepithelial mast cells with a unique protease phenotype in TH2-high asthma
Dougherty, R. H., Sidhu, S. S., Raman, K., Solon, M., Solberg, O. D., Caughey, G. H., Woodruff, P. G., & Fahy, J. V. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.03.003 · Cited by 254
Self-citationSafety and tolerability of omalizumab
Corren, J., Casale, T. B., Lanier, B., Buhl, R., Holgate, S., & Jimenez, P. (2009) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2009.03214.x · Cited by 252
Association Between Neutrophilic Airway Inflammation and Airflow Limitation in Adults With Asthma
Shaw, D. E., Berry, M. A., Hargadon, B., McKenna, S., Shelley, M. J., Green, R. H., Brightling, C. E., Wardlaw, A. J., & Pavord, I. D. (2007) · Chest · doi:10.1378/chest.07-1047 · Cited by 238
Ferreira, M. A. R., Matheson, M. C., Tang, C. S., Granell, R., Ang, W., Hui, J., Kiefer, A. K., Duffy, D. L., Baltic, S., Danoy, P., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.10.030 · Cited by 216
Epidemiology of Asthma: Prevalence and Burden of Disease
Croisant, S. (2014) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4614-8603-9_2 · Cited by 178
Structural Basis of Signaling Blockade by Anti-IL-13 Antibody Lebrikizumab
Ultsch, M., Bevers, J., Nakamura, G., Vandlen, R., Kelley, R. F., Wu, L. C., & Eigenbrot, C. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.01.024 · Cited by 174
Dose-ranging study of lebrikizumab in asthmatic patients not receiving inhaled steroids
Noonan, M., Korenblat, P., Mosesova, S., Scheerens, H., Arron, J. R., Zheng, Y., Putnam, W. S., Parsey, M. V., Bohen, S. P., & Matthews, J. G. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.03.051 · Cited by 171
Pathophysiology of bronchial smooth muscle remodelling in asthma
Bara, I., Ozier, A., Tunon de Lara, J.-M., Marthan, R., & Berger, P. (2010) · European Respiratory Journal · doi:10.1183/09031936.00019810 · Cited by 161
Tsabouri, S., Tseretopoulou, X., Priftis, K., & Ntzani, E. E. (2014) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2014.02.001 · Cited by 151
Efficacy and safety of an anti–IL-13 mAb in patients with severe asthma: A randomized trial
Boever, E. H. D., Ashman, C., Cahn, A. P., Locantore, N., Overend, P., Pouliquen, I. J., Serone, A., Wright, T. J., Jenkins, M., Panesar, I. S., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.01.002 · Cited by 145
Epigenetic regulation of asthma and allergic disease
Bégin, P., & Nadeau, K. C. (2014) · Allergy Asthma and Clinical Immunology · doi:10.1186/1710-1492-10-27 · Cited by 143
Consistency of sputum eosinophilia in difficult-to-treat asthma: A 5-year follow-up study
van Veen, I. H., Brinke, A. T., Gauw, S. A., Sterk, P. J., Rabe, K. F., & Bel, E. H. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.06.029 · Cited by 114
Egan, R. W., Athwal, D., Bodmer, M., Carter, J., Chapman, R. W., Choua, C.-C., Coxa, M., Emtage, S., Fernandez, X., Genatt, N., et al. (2011) · Arzneimittelforschung · doi:10.1055/s-0031-1300502 · Cited by 112
May, R. D., Monk, P., Cohen, E. S., Manuel, D. V. F. P., Dempsey, F. C., Davis, N. H. E., Dodd, A., Corkill, D. J., Woods, J. M., Joberty-Candotti, C., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01659.x · Cited by 107
Liu, Y., Zhang, S., Li, D., & Jiang, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059872 · Cited by 106
Vascular remodeling is a feature of asthma and nonasthmatic eosinophilic bronchitis
Siddiqui, S., Sutcliffe, A., Shikotra, A., Woodman, L. B., Doe, C., McKenna, S., Wardlaw, A. J., Bradding, P. H., Pavord, I. D., & Brightling, C. E. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.05.028 · Cited by 94
Asthma phenotypes and endotypes: an evolving paradigm for classification.
Corren, J. (2013) · PubMed · Cited by 94
Clinical update on the use of biomarkers of airway inflammation in the management of asthma
Wadsworth, S. J., Sin, D. D., & Dorscheid (2011) · Journal of Asthma and Allergy · doi:10.2147/jaa.s15081 · Cited by 84
Thymic Stromal Lymphopoietin-Mediated Extramedullary Hematopoiesis Promotes Allergic Inflammation
Siracusa, M. C., Saenz, S. A., Wojno, E. D. T., Kim, B., Osborne, L. C., Ziegler, C. G. K., Benitez, A., Ruymann, K., Färber, D. L., Abou‐Sleiman, P. M., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.09.016 · Cited by 80
Sorkness, C. A., Wildfire, J. J., Calatroni, A., Mitchell, H., Busse, W. W., O’Connor, G. T., Pongracic, J. A., Ross, K. R., Gill, M. A., Kattan, M., et al. (2013) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2013.01.011 · Cited by 79
Cooper, P. J., Ayre, G., Martín, C., Rizzo, J. Â., Ponte, E. V., & Cruz, Á. A. (2008) · Allergy · doi:10.1111/j.1398-9995.2007.01601.x · Cited by 78
A qPCR‐based metric of Th2 airway inflammation in asthma
Bhakta, N. R., Solberg, O. D., Nguyen, C. P., Nguyen, C. N., Arron, J. R., Fahy, J. V., & Woodruff, P. G. (2013) · Clinical and Translational Allergy · doi:10.1186/2045-7022-3-24 · Cited by 73
Self-citationHeterogeneity of Bronchitis in Airway Diseases in Tertiary Care Clinical Practice
D’silva, L., Hassan, N., Wang, H., Kjarsgaard, M., Efthimiadis, A., Hargreave, F. E., & Nair, P. K. (2011) · Canadian Respiratory Journal · doi:10.1155/2011/430317 · Cited by 72
From phenotypes to endotypes to asthma treatment
Agache, I. O. (2013) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0b013e32836093dd · Cited by 62
Hodsman, P., Ashman, C., Cahn, A. P., Boever, E. H. D., Locantore, N., Serone, A., & Pouliquen, I. J. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04334.x · Cited by 57
Airway inflammation and basement membrane tenascin in newly diagnosed atopic and nonatopic asthma
Karjalainen, E.-M., Lindqvist, A. E., Laitinen, L. A., Kava, T., Altraja, A., Halme, M. K., & Laitinen, A. (2003) · Respiratory Medicine · doi:10.1016/s0954-6111(03)00136-7 · Cited by 57
Virus-induced eosinophil mediator release requires antigen-presenting and CD4+ T cells
Davoine, F., Cao, M., Wu, Y., Ajamian, F., Ilarraza, R., Kokaji, A. I., Moqbel, R., & Adamko, D. J. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.03.028 · Cited by 54
Beigelman, A., Weinstock, G. M., & Bacharier, L. B. (2014) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000036 · Cited by 53
Management of Asthma: The Current US and European Guidelines
Reddy, A. P., & Gupta, M. R. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-8603-9_6 · Cited by 52
Hanania, N. A., Noonan, M. J., Corren, J., Korenblat, P. E., Zheng, Y., Putnam, W. S., Murray, E., Abelardo, C., Scheerens, H., Maciuca, R. D., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.12.1064 · Cited by 21
Oral corticosteroid-dependent asthma: a 30-year review
Randhawa, I., & Klaustermeyer, W. B. (2007) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)60543-1 · Cited by 16
Cited by
Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma
Castro, M., Corren, J., Pavord, I. D., Maspero, J., Wenzel, S., Rabe, K. F., Busse, W. W., Ford, L., Sher, L., FitzGerald, J. M., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1804092 · Cited by 1,986
The basic immunology of asthma
Hammad, H., & Lambrecht, B. N. (2021) · Cell · doi:10.1016/j.cell.2021.02.016 · Cited by 1,105
After asthma: redefining airways diseases
Pavord, I. D., Beasley, R., Agusti, A., Anderson, G. P., Bel, E., Brusselle, G., Cullinan, P., Custovic, A., Ducharme, F. M., Fahy, J. V., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)30879-6 · Cited by 1,073
Self-citationMetabolic Inflammation and Insulin Resistance in Obesity
Wu, H., & Ballantyne, C. M. (2020) · Circulation Research · doi:10.1161/circresaha.119.315896 · Cited by 1,059
Lambrecht, B. N., Hammad, H., & Fahy, J. V. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.018 · Cited by 1,039
Self-citation
Metadata
- Authors
- Fahy, J. V.
- Venue
- Nature Reviews Immunology
- Published
- 2014-12-23
- Volume
- 15
- Issue
- 1
- Pages
- 57-65
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2061435251
- Cited by
- 1,654
- References
- 76
- FWCI
- 8.39
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.